News

With new funding, researchers aim to control pain without the risk of addiction.

Neuroscientist Candice Contet and colleagues to take a close look how an understudied brain region promotes alcohol drinking.

The grant builds upon previous work from the Rumbaugh lab that uncovered a sensitive period in brain development.

Amidst a nation-wide opioid epidemic, scientists at The Scripps Research Institute are making strides in developing new, non-opioid pain medications. 

Scripps Translational Science Institute to lead the national Participant Center and the program’s use of mobile technologies for each individual to collect their health data.

“There is a dire need for the development of new, effective and safe therapies against chronic lymphocytic leukemia.”

Data from individual patients could hold clues to stopping Ebola virus and related killers.

The center includes scientists from both the California and Florida campuses of Scripps Research.

Informatics experts at Scripps Research have been awarded close to $3 million as part of a five-year cooperative agreement to launch the National Center for Data to Health (CD2H).

Patrick R. Griffin, co-chair of the Department of Molecular Medicine on the Florida campus of Scripps Research, has been awarded a $2.5 million collaborative grant with Brigham and Women’s Hospital.

"Clearly, there is an urgent need to develop better options for these patients."

"It is one of the most productive large-scale science grants that NIAID funds."

A team of scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $2 million from the National Institute of Mental Health of the National Institutes of Health.

"The new grant supports the idea that RNA is a legitimate target to treat disease."

Assistant Professor Seth Tomchik of the Florida campus of The Scripps Research Institute (TSRI) has received $2 million in funding from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS).

The Nuclear Magnetic Resonance (NMR) facility at the Florida campus of Scripps Florida is becoming one of the most advanced in South Florida, thanks to a new $600,000 grant from the National Institutes of Health.

The new funding will support a five-year project, led by Professor Michael Farzan, to bring a potential HIV vaccine closer to human clinical trials.

"At Scripps Florida we not only do great science, but we have even greater opportunities to collaborate on projects like this."

The co-principal investigators of the three-year project are TSRI Professor William R. Roush and Associate Professor Derek Duckett.